A detailed history of Mosley Wealth Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Mosley Wealth Management holds 1,063 shares of LLY stock, worth $802,565. This represents 0.66% of its overall portfolio holdings.

Number of Shares
1,063
Previous 908 17.07%
Holding current value
$802,565
Previous $822 Million 17.17%
% of portfolio
0.66%
Previous 0.7%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $119,681 - $148,803
155 Added 17.07%
1,063 $963 Million
Q2 2024

Aug 06, 2024

SELL
$724.87 - $909.04 $76,836 - $96,358
-106 Reduced 10.45%
908 $822 Million
Q1 2024

Apr 15, 2024

SELL
$592.2 - $792.28 $21,911 - $29,314
-37 Reduced 3.52%
1,014 $789 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $551,974 - $650,705
1,051 New
1,051 $613 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $717B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mosley Wealth Management Portfolio

Follow Mosley Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mosley Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Mosley Wealth Management with notifications on news.